Blogs about: Sabcs
Featured Blog
Phase III Trial Did Not Show Superiority of Eribulin Compared With Capecitabine in Metastatic Breast Cancer
Eribulin showed trend toward improved overall survival versus capecitabine. Eribulin showed greater activity in certain subsets of patients. Researchers are still gathering quality-of-life data. SAN A… more →
AACR News
The sentinel lymph node biopsy and neoadjuvant chemotherapy
wrote 3 months ago: Sentinel lymph node biopsy (SLNB) is an established technique to accurately assess the status of the … more →
In focus: Triple Negative Breast Cancer
— 4 comments
wrote 4 months ago: Latest research efforts reported in the San Antonio Breast Cancer Symposium, 2012 Curator: Ritu Saxe … more →
Update from SABCS from Guest blogger Joan at SHARE
wrote 5 months ago: We are reblogging this excellent post from Joan at SHARE. She focuses on the issues that apply to me … more →
Longer Duration of Tamoxifen Therapy Shows Benefit
wrote 6 months ago: For women with estrogen receptor-positive breast cancer, treatment with 5 years of tamoxifen is know … more →
Random Acts of Science and Business: Reflections on the San Antonio Breast Cancer Symposium
— 4 comments
wrote 6 months ago: After attending my fifth San Antonio Breast Cancer Symposium it seems, once again, that we are inchi … more →
San Antonio Breast Cancer Symposium (SABCS)
— 1 comment
wrote 6 months ago: Below is information taken from the San Antonio Breast Cancer Symposium (SABCS) web site explaining … more →
Report from SABCS from a patient advocate
— 10 comments
wrote 6 months ago: Shirley and I are here in San Antonio at SABCS (San Antonio Breast Cancer Symposium), a premier conf … more →
Cognitive Problems May Be Present Before Chemotherapy in Women With Breast Cancer
wrote 6 months ago: “Chemo brain” may be an inaccurate descriptor of cognitive issues. Fatigue is a key cont … more →
Breast Cancer Genome Sequencing Identified HER2 Mutations as Targets for Drug Treatment
wrote 6 months ago: HER2 mutations occurred separately from HER2 gene amplification and DNA sequencing is required to de … more →
Adjuvant Bevacizumab Did Not Improve Invasive Disease-free Survival in Triple-negative Breast Cancer
wrote 6 months ago: Safety profile was consistent with previous trials of bevacizumab. More understanding of triple-nega … more →
Phase III Trial Did Not Show Superiority of Eribulin Compared With Capecitabine in Metastatic Breast Cancer
wrote 6 months ago: Eribulin showed trend toward improved overall survival versus capecitabine. Eribulin showed greater … more →
Extending Adjuvant Trastuzumab Treatment Time Provided No Additional Benefit
wrote 6 months ago: High number of patients who received one year of trastuzumab were disease-free eight years later. On … more →
Chemotherapy After Complete Surgical Removal of Local or Regional Breast Cancer Recurrence Increased Survival Rates
wrote 6 months ago: Disease-free and overall survival improved with postsurgical chemotherapy. Patients with ER-negative … more →
Young Women With Breast Cancer Were More Likely Than Older Women to Respond to Neoadjuvant Chemotherapy
wrote 6 months ago: Finding was confined to those with triple-negative and luminal-type breast cancer. Better outcomes s … more →
Diverse Genetic Alterations Found in Triple-negative Breast Cancers After Neoadjuvant Chemotherapy
wrote 6 months ago: Residual tumor cells are found in up to 70 percent of these patients. Multiple types of potentially … more →
Hypofractionated Radiotherapy Was Safe, Effective for Early Breast Cancer Treatment at 10-year Follow-up
wrote 6 months ago: Low local relapse rates were observed after breast cancer radiotherapy. Lower total radiation dose i … more →
HDAC Inhibitors Sensitized Triple-negative Breast Cancer Cells to PARP Inhibition and Cisplatin Treatment
wrote 6 months ago: HDAC inhibitors indirectly caused DNA damage and impaired DNA repair. Cellular conditions created by … more →
Sentinel Lymph Node Surgery After Chemotherapy Demonstrated Accuracy in Nodal Staging for Certain Patients With Breast Cancer
wrote 6 months ago: Presurgery chemotherapy eradicated lymph node disease in 40 percent of cases. Sentinel lymph node su … more →
Combination of Investigational Agent and Letrozole Demonstrated Clinical Benefit in Advanced ER-positive Breast Cancer
wrote 6 months ago: Combination improved progression-free survival and was well tolerated. Investigational agent is an o … more →
